Vittorio Meneghini
- Pathology and Forensic Medicine top 5%
- Oncology
- Genetics top 10%
- Neurology top 10%
- Hematology top 10%
- Co-authors
- G TodeschiniDino VeneriG. PeronaRoberta ZanottiAlberto AmbrosettiGiovanni PizzoloFabio BenedettiM. M. Ricetti
- Topics
- Lymphoma Diagnosis and Treatment (9 papers)Chronic Lymphocytic Leukemia Research (8 papers)Acute Lymphoblastic Leukemia research (7 papers)
In The Last Decade
Vittorio Meneghini
21 papers receiving 500 citations
Peers
Comparison fields: 5 of 63
- Pathology and Forensic Medicine 321
- Oncology 174
- Genetics 159
- Neurology 139
- Hematology 107
Countries citing papers authored by Vittorio Meneghini
This map shows the geographic impact of Vittorio Meneghini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vittorio Meneghini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vittorio Meneghini more than expected).
Fields of papers citing papers by Vittorio Meneghini
This network shows the impact of papers produced by Vittorio Meneghini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vittorio Meneghini. The network helps show where Vittorio Meneghini may publish in the future.
Co-authorship network of co-authors of Vittorio Meneghini
This figure shows the co-authorship network connecting the top 25 collaborators of Vittorio Meneghini. A scholar is included among the top collaborators of Vittorio Meneghini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vittorio Meneghini. Vittorio Meneghini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma? | 8 |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 69 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 27 | |
| 10 | 54 | |
| 11 | 27 | |
| 12 | Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN). | 4 |
| 13 | Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin). | 12 |
| 14 | Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients | 3 |
| 15 | 14 | |
| 16 | 83 | |
| 17 | 40 | |
| 18 | 1 | |
| 19 | 41 | |
| 20 | 80 |
About Vittorio Meneghini
Vittorio Meneghini is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 21 papers that have together received 516 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (321 citations), Genetics (159 citations) and Hematology (107 citations). Vittorio Meneghini has collaborated with scholars based in Italy, Poland and Austria. Frequent co-authors include G Todeschini, Dino Veneri, G. Perona, Roberta Zanotti, Alberto Ambrosetti, Giovanni Pizzolo, Fabio Benedetti, M. M. Ricetti, Cristina Tecchio and Umberto Vitolo. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.